| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 09/03/2008 | EP1962840A1 Use of 4, 7-dihydrothieno [2, 3-b]pyridine compounds in the treatment of cardiovascular diseases |
| 09/03/2008 | EP1962826A2 Method for weight reduction |
| 09/03/2008 | EP1909835A4 Methods and compositions for treating female infertility using clomiphene |
| 09/03/2008 | EP1879581B1 4-PHENYL-5-0X0-l,4,5,6,7,8-HEXAHYDR0QËIN0LINE DERIVATIVES AS MEDICAMENTS FOR THE TREATMENT OF INFERTILITY |
| 09/03/2008 | EP1761497B1 Azadecalin glucocorticoid receptor modulators |
| 09/03/2008 | EP1343781B1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| 09/03/2008 | CN101258159A Novel c18 modified retrosteroids as progesterone receptor modulator compounds |
| 09/03/2008 | CN100415718C CASPASE inhibitors and use thereof |
| 09/02/2008 | US7420061 Process for preparing prodrugs of benzenesulfonamide-containing COX-2 inhibitors |
| 09/02/2008 | US7419998 Therapeutic methods and compositions involving isoflavones |
| 09/02/2008 | US7419987 7-azaindoles, their use as inhibitors of phosphodiesterase 4, and a method for synthesizing them |
| 09/02/2008 | US7419983 Gonadotropin-releasing hormone receptor antagonists and methods related thereto |
| 09/02/2008 | US7419799 Medical diagnosis; gene expression; genetic engineering; cell proliferation |
| 09/02/2008 | US7419670 Method of treating arthritis with SERP-1 and an immunosuppressant |
| 09/02/2008 | CA2351665C Antagonistic analogs of gh-rh inhibiting igf-i and -ii |
| 09/02/2008 | CA2306881C Methods for treating postmenopausal women using ultra-low doses of estrogen |
| 08/28/2008 | WO2008103707A1 Mono-and di-phosphates of 3-(3-fluoro-4-hydroxy-phenyl)-7-hydroxy-naphthalene-1-carbonitrile |
| 08/28/2008 | WO2008102749A1 Heterocyclic compound |
| 08/28/2008 | WO2008033851A3 Use of 2-6- (3-amino-piperidin-l-yl) -3-methyl-2, 4-dioxo-3, 4-dihydr0-2h-pyrimidin-1-ylmet hyl-4-fluoro-benzonitrile |
| 08/28/2008 | US20080207746 Administering an ultrasonic contrast agent; imaging tissue; medical diagnosis; using halogenated xanthene compound |
| 08/28/2008 | US20080207680 Antiinflammatory agents; antiallergens; neurodegrative disease ; autoimmune disease; antiarthritic agents |
| 08/28/2008 | US20080207543 Modified pituitary gland development in offspring from expectant mother animals treated with growth hormone releasing hormone therapy |
| 08/28/2008 | US20080207524 Medicinal preparations for treating sex hormone-dependent diseases |
| 08/28/2008 | US20080206267 Inactivation Of Genes Of The Mep Pathway |
| 08/27/2008 | EP1960417A1 Polymorphs of androgen receptor modulator - (n-3h-imidazo [4 , 5-b] pyridin-2-yl-methyl) -2-fluoro-4-methyl-3-oxo-4-aza-androst- 1-en-17 . beta . -carboxamide |
| 08/27/2008 | EP1960347A2 17-beta-hydroxysteroid dehydrogenase type 3 (17beta-hsd3) inhibitors |
| 08/27/2008 | EP1411916B1 Methods and materials for the treatment of testosterone deficiency in men |
| 08/27/2008 | EP1337560B1 Truncated cd200 |
| 08/27/2008 | CN101249136A Applications of compound red sage root tablet for pharmacy |
| 08/27/2008 | CN100413885C Modified proteins, designer toxins and methosd of making thereof |
| 08/26/2008 | US7417029 Using an interleukin-1 beta converting enzyme inhibitor pro-drug to treat apoptosis-, interferon-gamma inducing factor or interferon-gamma inducing diseases; antiinflammatory and -proliferative agents; autoimmune/degenerative disesesdiseases |
| 08/26/2008 | US7416885 Proliferation factor is obtained from the UCHT1 rat thyroid cell line, or a fragment, analogue or derivateve |
| 08/26/2008 | US7416858 Forming a convalent conjugate of a peptide, removing X2 or a saccharyl subunit thereof from peptide forming a truncated glycan; contacting truncated glycan with glycosyltransferase and modified sugar donor under conditions suitable for glycosyltransferase to transfer a modified sugar moiety |
| 08/26/2008 | CA2432129C Pyrazole compounds useful as protein kinase inhibitors |
| 08/26/2008 | CA2392165C Vitamin d analogues |
| 08/26/2008 | CA2333669C 17.beta.-amino and hydroxylamino-11.beta.-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 08/21/2008 | WO2008100560A2 Estrogen receptor modulators, associated pharmaceutical compositions and methods of use |
| 08/21/2008 | WO2008099969A1 Anti-fgf23 antibody and pharmaceutical composition comprising the same |
| 08/21/2008 | WO2008099185A1 Human monoclonal antibodies to the thyrotropin receptor which act as antagonists |
| 08/21/2008 | WO2008098977A1 Novel triazole derivatives as ligands of g-protein coupled receptors |
| 08/21/2008 | US20080200494 Imidazopyridine Derivatives |
| 08/21/2008 | US20080200433 Molecular Chaperone Function Regulator |
| 08/21/2008 | US20080199917 Using vector comprising early gene modifications as genetic transfer element in gene therapy; gnentic vaccines |
| 08/21/2008 | CA2677782A1 Anti fgf23 antibody and a pharmaceutical composition comprising the same |
| 08/20/2008 | EP1958631A1 Novel triazole derivatives as ligands of G-protein coupled receptors |
| 08/20/2008 | EP1957515A2 PRODRUG ERbeta-SELECTIVE SUBSTANCES, METHODS FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAID COMPOUNDS |
| 08/20/2008 | EP1957514A1 Prodrugs of er-beta-selective substances method for production thereof and pharmaceutical compositions comprising the same |
| 08/20/2008 | EP1957513A2 Sulfamoyl sulfonate prodrugs |
| 08/20/2008 | EP1957512A1 17.beta.-fluoromethoxycarbonyl-androst-4-en-3-one compounds with a 17.alpha.-carbonate substituent |
| 08/20/2008 | EP1957489A2 Bis-heterocyclic imidazolyl compounds |
| 08/20/2008 | EP1957059A1 Androgen-receptor (ar) ligands for use in the treatment and diagnosis of ar-related pathologies |
| 08/20/2008 | EP1957054A2 Fast-acting oral peptide pharmaceutical products |
| 08/20/2008 | EP1836215B1 Androstane 17-alpha-carbonate for use in the treatment of inflammatory and allergic conditions |
| 08/20/2008 | EP1556488B1 Hf-chondroosteomodulin, production, and use for the treatment or diagnosis of bone diseases, cartilage diseases, obesity, inflammatory diseases, and skin diseases |
| 08/20/2008 | EP1456203B1 Ethylene diamine derivatives and their use as orexin-receptor antagonists |
| 08/20/2008 | EP1289993B9 Caspase inhibitors and uses thereof |
| 08/20/2008 | CN101248066A Non-steroidal progesterone receptor modulators |
| 08/20/2008 | CN101247803A Use of a steroid sulphatase inhibitor for inhibiting the synthesis of androstenedione and/or testosterone |
| 08/20/2008 | CN101245002A Process for producing steady iodination vegetable oil, iodination vegetable oil fatty acid ethyl ester |
| 08/20/2008 | CN101244232A Application of anemarrhena asphodefoides extract in preparing medicaments for improving insulin resistance |
| 08/20/2008 | CN101244202A Chinese medicine oral administration solid preparations, preparation, quality control method and uses thereof |
| 08/20/2008 | CN100412091C Analogs of parathyroid hormone |
| 08/20/2008 | CN100412073C Novel thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions |
| 08/20/2008 | CN100411683C Medicinal compositions containing ghrelin |
| 08/20/2008 | CN100411626C Preparing method of slow-released type iodine complement agent |
| 08/19/2008 | US7414122 host cell, viral vector; agonists and antagonists; diagnosis or treatment of cancer; antiproliferative; infertility, miscarriage, preterm labor and delivery, and endometriosis; immunosuppressants; vaccine adjuvants; genetic mapping |
| 08/19/2008 | US7414107 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
| 08/19/2008 | US7413754 Administering a photoestrogen for treating urinary bladder infection and dry vagina; plant extracts is obtained from solvent extraction |
| 08/19/2008 | CA2461567C Substituted pyrazolyl benzenesulfamide compounds for the treatment of inflammation |
| 08/19/2008 | CA2432799C Pyrazole compounds useful as protein kinase inhibitors |
| 08/14/2008 | WO2008096769A1 Pharmaceutical compositions containing substituted cercosporamide derivatives |
| 08/14/2008 | WO2008095809A1 Nitric oxide releasing steroids |
| 08/14/2008 | WO2008095808A1 Nitric oxide releasing steroids |
| 08/14/2008 | WO2008095806A1 Nitric oxide releasing steroids |
| 08/14/2008 | US20080194797 Leucine-based motif and clostridial neurotoxins |
| 08/14/2008 | US20080194672 Growth hormone secretagogue (ghrelin) receptor; gastrointestinal disorders; gastroesophageal reflux disease (GERD), gastric ulcers, Crohn's disease |
| 08/14/2008 | US20080194622 Antidepressants; anxiolytic agents;schizophrenia; cognition activators |
| 08/14/2008 | US20080194553 compounds that are capable of increasing the serum level of insulin-like growth factor 1 (IGF-1) for the preparation of a therapeutical composition,in the form of a food supplement, for the treatment of subjects suffering from serious fatigue and exhausting symptoms, burn-out and chronic fatigue syndrome |
| 08/14/2008 | US20080194533 Sulfating 17 beta-dihydroequilin or 17 beta-estradiol using tertiary amine-sulfur trioxide complexes and sodium, lithium or potassium salt formation; hormone replacement therapy; hot flashes in postmenopausal women; endometriosis, breast cancer |
| 08/14/2008 | US20080193432 Alpha -tocopherol, hydro-Q9 chromene, coenzyme Q9, cycloartane, 1-Feruloyl glycerol; activates estrogen receptors; improving menopause symptoms |
| 08/14/2008 | CA2677442A1 Nitric oxide releasing steroids |
| 08/14/2008 | CA2677441A1 Nitric oxide releasing steroids |
| 08/14/2008 | CA2677290A1 Nitric oxide releasing steroids |
| 08/13/2008 | EP1956020A2 1-[2-(heterocyclyl-aminomethyl)-piperidin-1-YL]-1-(2-methyl-5-phenyl-heterocyclyl)-methanone derivatives and related compounds as orexin-1 antagonists for the treatment of obesity |
| 08/13/2008 | EP1495030B1 Non-steroidal progesterone receptor modulators |
| 08/13/2008 | EP1489088B1 Novel alpha-amino-n-(diaminophosphinyl)lactam derivative |
| 08/13/2008 | EP1467979B1 Fused heterocyclic compounds and analogs thereof modulators of nuclear hormone receptor function |
| 08/13/2008 | EP1463801B1 Transdifferentiation of pancreatic acinar cells |
| 08/13/2008 | EP1064308B1 Methods for identifying inducers and inhibitors of proteolytic antibodies, compositions and their uses |
| 08/13/2008 | CN101241127A Sgk and Nedd used as diagnostic and therapeutic targets |
| 08/13/2008 | CN101240262A Islet cells from human embryonic stem cells |
| 08/13/2008 | CN101240015A Core-peptide composition with physiological activity and its preparation method and application |
| 08/13/2008 | CN101239125A Capable of improving endocrine function |
| 08/13/2008 | CN100410250C Spiroheterocyclic compoundsus reversible inhibitors of cysteine proteases |
| 08/12/2008 | US7411072 e.g. 5-(10,11-Dihydro-dibenzo[a,d]cyclohepten-5-ylidenemethyl)-3H-benzooxazol-2-one; antiinflammatory, antidiabetic agent; electrolytes and water retention modulator; hypotensive, hypoglycemic agent; arrhythmias, myocardial fibrosis, osteoporosis, polyuria, polydipsia, Crohn's disease |
| 08/12/2008 | US7410991 Pyrazolidinone compounds as ligands of the prostaglandin EP2 and/or EP4 receptors |
| 08/12/2008 | US7410799 In vivo production and delivery of erythropoietin or insulinotropin for gene therapy |
| 08/12/2008 | US7410774 Compounds modulating sister chromatid separation and method for identifying same |
| 08/12/2008 | US7410642 Assays and therapies for latent viral infection |
| 08/12/2008 | US7410641 Hybridoma and monoclonal antibodies produced; insulin-like growth factor (IGF); diagnosis, treatment, prevention of diabetes and metabolic disorders |